Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul 30;11(7):e5280.
doi: 10.7759/cureus.5280.

Major Adverse Cardiovascular Events: An Inevitable Outcome of ST-elevation myocardial infarction? A Literature Review

Ishan Poudel  1 , Chavi Tejpal  2 , Hamza Rashid  3 , Nusrat Jahan  1
Affiliations
Review

Major Adverse Cardiovascular Events: An Inevitable Outcome of ST-elevation myocardial infarction? A Literature Review

Ishan Poudel et al. Cureus. .

Abstract

Major adverse cardiovascular events (MACE) remain the major cause of mortality and morbidity in patients with STEMI (ST-elevation myocardial infarction). The current literature is aimed to analyze the occurrence of MACE following STEMI irrespective of treatment provided, and follow up after the first diagnosis of STEMI. A PubMed search for Studies of STEMI identified 24,244 articles. After applying our inclusion/exclusion criteria, we found out 75 articles of relevance wherein MACE and its components were considered to be the primary endpoint. These 75 articles included eight Cohort Studies, 13 clinical trials including five randomized controlled trials (RCT), one case-control Study, one cross-sectional study, one review article, and 51 other observational studies. Our analysis shows that MACE remains one of the strongest adverse outcomes among STEMI patients. The current literature review found out the incidence of MACE was 4.2 % to 51% irrespective of the mode of treatment, and follow-ups lasting up to 10 years from the time of STEMI diagnosis.

Keywords: stemi; stemi complications; stemi major adverse cardiovascular events; stemi review.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Flow chart showing the process of current literature review
See this image and copyright information in PMC

References

    1. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. O’Gara PT, Kushner FG, Ascheim DD, et al. Circulation. 2013;127 - PubMed
    1. Third universal definition of myocardial infarction. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Circulation. 2012;126:2020–2035. - PubMed
    1. Usefulness of quantitative and qualitative angiographic lesion morphology, and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty. Hermans WRM, Foley DP, Rensing BJ, et al. Am J Cardiol. 1993;72:14–20. - PubMed
    1. Clinical and angiographic outcome following implantation of the new less shortening wallstent in aortocoronary vein grafts: introduction of a second generation stent in the clinical arena. Keane D, Buis B, Reifart N, et al. J Interv Cardiol. 1994;7:557–564. - PubMed
    1. The burden of major adverse cardiac events in patients with coronary artery disease. Tsai IT, Wang CP, Lu YC, et al. BMC Cardiovasc Disord. 2017;17:1. - PMC - PubMed

LinkOut - more resources